These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Tropea KA; Leder E; Aslam M; Lau AN; Raiser DM; Lee JH; Balasubramaniam V; Fredenburgh LE; Alex Mitsialis S; Kourembanas S; Kim CF Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L829-37. PubMed ID: 22328358 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia. Jiménez J; Lesage F; Richter J; Nagatomo T; Salaets T; Zia S; Mori Da Cunha MG; Vanoirbeek J; Deprest JA; Toelen J Neonatology; 2018; 113(3):275-285. PubMed ID: 29393249 [TBL] [Abstract][Full Text] [Related]
6. Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD. Ali M; Heyob K; Tipple TE; Pryhuber GS; Rogers LK Respir Res; 2018 Nov; 19(1):229. PubMed ID: 30463566 [TBL] [Abstract][Full Text] [Related]
7. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189 [TBL] [Abstract][Full Text] [Related]
9. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia. Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658 [TBL] [Abstract][Full Text] [Related]
10. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Popova AP; Bentley JK; Cui TX; Richardson MN; Linn MJ; Lei J; Chen Q; Goldsmith AM; Pryhuber GS; Hershenson MB Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L231-9. PubMed ID: 24907056 [TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia. Moreira A; Winter C; Joy J; Winter L; Jones M; Noronha M; Porter M; Quim K; Corral A; Alayli Y; Seno T; Mustafa S; Hornsby P; Ahuja S Stem Cells Transl Med; 2020 Feb; 9(2):221-234. PubMed ID: 31774626 [TBL] [Abstract][Full Text] [Related]
12. EPO enhances the protective effects of MSCs in experimental hyperoxia-induced neonatal mice by promoting angiogenesis. Sun C; Zhang S; Wang J; Jiang W; Xin Q; Chen X; Zhang Z; Luan Y Aging (Albany NY); 2019 Apr; 11(8):2477-2487. PubMed ID: 31035257 [TBL] [Abstract][Full Text] [Related]
13. Single-Cell RNA Sequencing Reveals Repair Features of Human Umbilical Cord Mesenchymal Stromal Cells. Cyr-Depauw C; Cook DP; Mižik I; Lesage F; Vadivel A; Renesme L; Deng Y; Zhong S; Bardin P; Xu L; Möbius MA; Marzahn J; Freund D; Stewart DJ; Vanderhyden BC; Rüdiger M; Thébaud B Am J Respir Crit Care Med; 2024 Sep; 210(6):814-827. PubMed ID: 38564376 [No Abstract] [Full Text] [Related]
14. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury. Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256 [TBL] [Abstract][Full Text] [Related]
15. [Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats]. Wang XL; Xue XD Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):446-51. PubMed ID: 19951473 [TBL] [Abstract][Full Text] [Related]
16. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis. You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709 [TBL] [Abstract][Full Text] [Related]
18. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022 [TBL] [Abstract][Full Text] [Related]
19. Recombinant CXCL17 Treatment Alleviates Hyperoxia-Induced Lung Apoptosis and Inflammation In Vivo and Vitro by Activating the AKT Pathway: A Possible Therapeutic Approach for Bronchopulmonary Dysplasia. Chen P; Cheng Y; Hu J; Fang R; Yang LQ Mol Biotechnol; 2024 Sep; 66(9):2349-2361. PubMed ID: 37710083 [TBL] [Abstract][Full Text] [Related]
20. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia. Guerra K; Bryan C; Dapaah-Siakwan F; Sammour I; Drummond S; Zambrano R; Chen P; Huang J; Sharma M; Shrager S; Benny M; Wu S; Young KC Respir Res; 2019 Nov; 20(1):255. PubMed ID: 31718614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]